New Haven, Connecticut and monmouth junction, new jersey and Los Angeles, July 5, 2023 /PRNewswire/ — DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has acquired JADBio to utilize its automated machine learning (AutoML) platform and services. announced that it had signed a contract with It aims to develop predictive models based on the DiamiR microRNA panel and other factors for risk assessment of Alzheimer’s disease and Rett syndrome.
Dr. Alidad Mireskandari, CEO of DiamiR, said, “Applying machine learning capabilities to our microRNA platform is an important step towards validating diagnostic tests. We are a leader in automated machine learning in the life sciences. We are excited to partner with JADBio to develop sophisticated and proprietary ML-based testing algorithms to further our development efforts.”
JADBio’s CEO said: Pavlos Chaloniktakis“We believe our state-of-the-art ML platform and services will help DiamiR in its efforts to efficiently validate biomarker panels and develop highly accurate diagnostic tests.”
About DiamiR
DiamiR, a privately held molecular diagnostics company, is based on the quantitative analysis of organ-abundant microRNA signatures in plasma for screening, patient stratification, and monitoring of disease progression and treatment. We are focused on developing minimally invasive tests for the detection and monitoring of pathology. DiamiR works with leading academic centers, disease foundations and biopharmaceutical companies. For more information, please visit his website at www.diamirbio.com.
About JADBio
JADBio is an AutoML-based bioinformatics platform that enables life scientists to easily discover new biomarkers from public or proprietary research data and generate their own predictions without coding or ML expertise required. Allow the model to be built. JADBio enables bioinformaticians and data scientists to analyze all kinds of biomolecular data, with access through APIs to capabilities such as image analysis, batch analysis, and built-in SciKit Learn algorithms. For more information on JADBio, please visit jadbio.com.
This news release contains forward-looking statements regarding future events. These statements are predictions and are subject to risks and uncertainties that could cause actual events or results to differ materially.
contact:
Dr. Alidad Milescandari
203-570-8275
amireskandari@diamirbio.com
To download multimedia, view the original content: https://www.prnewswire.com/news-releases/diamir-biosciences-partners-with-jadbio-to-utilize-machine-learning-in- assay-development-301870112.html
Source DiamiR
